» Articles » PMID: 35992042

COVID-19 Vaccination, Implications for PET/CT Image Interpretation and Future Perspectives

Overview
Publisher Springer
Date 2022 Aug 22
PMID 35992042
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The present paper aims to systematically review the literature on COVID-19 vaccine-related findings in patients undergoing PET/CT.

Methods: The search algorithms included the following combination of terms: "PET" OR "positron emission tomography" AND "COVID"; "PET" OR "positron emission tomography" AND "COVID" AND "vaccination"; "PET" OR "positron emission tomography" AND "COVID", AND "autoimmune".

Results: We selected 17 articles which were assessed for quality and included in the systematic analysis. The most frequent vaccine-related signs on PET/CT were the deltoid [F]FDG uptake and axillary hypermetabolic lymph nodes, which were described in 8-71% and 7-90% of the patients, respectively. Similarly, frequency of these findings using other tracers than [F]FDG was greatly variable. This large variability was related to the variability in time elapsed between vaccination and PET/CT, and the criteria used to define positivity. In addition, vaccine-related findings were detected more frequently in young and immunocompetent patients than in elderly and immunocompromised ones.

Discussion: Therefore, awareness on vaccination status (timing, patient characteristics, and concurrent therapies) and knowledge on patterns of radiopharmaceutical uptake are necessary to properly interpret PET/CT findings.

Citing Articles

Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.

Giordano A, Gallicchio R, Milella M, Storto R, Nardelli A, Pellegrino T Curr Pharm Des. 2024; 30(10):798-806.

PMID: 38454762 DOI: 10.2174/0113816128246329231016091519.

References
1.
Ferrari C, Nappi A, Santo G, Mammucci P, Rubini D, Tucci M . The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET/CT and Impact on Oncologic Patients Management. Cancers (Basel). 2021; 13(17). PMC: 8431447. DOI: 10.3390/cancers13174340. View

2.
Advani P, Chumsri S, Pai T, Li Z, Sharma A, Parent E . Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients. Ann Nucl Med. 2021; 35(11):1264-1269. PMC: 8406005. DOI: 10.1007/s12149-021-01675-8. View

3.
Cohen D, Hazut Krauthammer S, Wolf I, Even-Sapir E . A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [F]FDG PET-CT studies performed in oncologic patients. Eur J Nucl Med Mol Imaging. 2021; 49(4):1338-1344. PMC: 8516623. DOI: 10.1007/s00259-021-05579-7. View

4.
Velikova T, Georgiev T . SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int. 2021; 41(3):509-518. PMC: 7846902. DOI: 10.1007/s00296-021-04792-9. View

5.
Pourfathi M, Kadlecek S, Chatterjee S, Rizi R . Metabolic Imaging and Biological Assessment: Platforms to Evaluate Acute Lung Injury and Inflammation. Front Physiol. 2020; 11:937. PMC: 7487972. DOI: 10.3389/fphys.2020.00937. View